ArcBlock
Abbott Laboratories (ABT) Stock: NACHC Partnership Targets Better Nutrition Access
Abbott and NACHC expand nutrition-focused healthcare through training and certification.
Abbott Laboratories (ABT) Stock Surges 4% on Strong Q2 Results and Upgraded Guidance
Abbott Laboratories delivered second-quarter results that exceeded Wall Street projections and boosted its full-year earnings forecast, propelling ABT shares up approximately 4% during premarket hours Thursday.
Abbott Laboratories (ABT) Stock Falls 4.3% After Q1 Earnings Despite Revenue Beat
Shares of Abbott Laboratories (ABT) tumbled in pre-market hours despite delivering robust first-quarter revenue figures and maintaining steady earnings. The healthcare giant's decision to lower its full-year profit outlook coupled with deteriorating operating margins spooked investors, raising red flags about the company's ability to maintain profitability.
Abbott Laboratories (ABT) Q1 2026 Results: Revenue Surpasses Expectations on Cancer Diagnostics Strength
Abbott Laboratories delivered first-quarter financial results on April 16 that exceeded Wall Street's revenue projections, with its recently completed cancer diagnostics acquisition providing additional momentum.
